Skip to main navigation Skip to search Skip to main content

Impact of adherence to antidepressants on long-term prescription opioid use cessation

  • Jeffrey F. Scherrer
  • , Joanne Salas
  • , Mark D. Sullivan
  • , Brian K. Ahmedani
  • , Laurel A. Copeland
  • , Kathleen K. Bucholz
  • , Thomas Burroughs
  • , F. David Schneider
  • , Patrick J. Lustman

Research output: Contribution to journalArticlepeer-review

Abstract

Background Depression contributes to persistent opioid analgesic use (OAU). Treating depression may increase opioid cessation. Aims To determine if adherence to antidepressant medications (ADMs) v. non-adherence was associated with opioid cessation in patients with a new depression episode after >90 days of OAU. Method Patients with non-cancer, non-HIV pain (n = 2821), with a new episode of depression following >90 days of OAU, were eligible if they received =1 ADM prescription from 2002 to 2012. ADM adherence was defined as >80% of days covered. Opioid cessation was defined as =182 days without a prescription refill. Confounding was controlled by inverse probability of treatment weighting. Results In weighted data, the incidence rate of opioid cessation was significantly (P = 0.007) greater in patients who adhered v. did not adhered to taking antidepressants (57.2/1000 v. 45.0/1000 person-years). ADM adherence was significantly associated with opioid cessation (odds ratio (OR) = 1.24, 95% CI 1.05-1.46). Conclusions ADM adherence, compared with non-adherence, is associated with opioid cessation in non-cancer pain. Opioid taper and cessation may be more successful when depression is treated to remission.

Original languageEnglish
Pages (from-to)103-111
Number of pages9
JournalBritish Journal of Psychiatry
Volume212
Issue number2
DOIs
StatePublished - Feb 2018

Fingerprint

Dive into the research topics of 'Impact of adherence to antidepressants on long-term prescription opioid use cessation'. Together they form a unique fingerprint.

Cite this